Display options
Cite
Harsimran K, Kaur MG, Nitika S, et al. Chromosomal instability in the lymphocytes of breast cancer patients. Indian J Hum Genet. 2009;15(1):13-8doi: 10.4103/0971-6866.50864.
Harsimran, K., Kaur, M. G., Nitika, S., Meena, S., M S, U., Yamini, A P S, B., & Vasudha, S. (2009). Chromosomal instability in the lymphocytes of breast cancer patients. Indian journal of human genetics, 15(1), 13-8. https://doi.org/10.4103/0971-6866.50864
Harsimran, Kaur, et al. "Chromosomal instability in the lymphocytes of breast cancer patients." Indian journal of human genetics vol. 15,1 (2009): 13-8. doi: https://doi.org/10.4103/0971-6866.50864
Harsimran K, Kaur MG, Nitika S, Meena S, M S U, Yamini, A P S B, Vasudha S. Chromosomal instability in the lymphocytes of breast cancer patients. Indian J Hum Genet. 2009 Jan;15(1):13-8. doi: 10.4103/0971-6866.50864. PMID: 20407644; PMCID: PMC2846563.
Copy Download .nbib Format: NLM
Share it on

Indian J Hum Genet. 2009 Jan;15(1):13-8. doi: 10.4103/0971-6866.50864.

Chromosomal instability in the lymphocytes of breast cancer patients.

Indian journal of human genetics

Kaur Harsimran, Monga Gaganpreet Kaur, Setia Nitika, Sudan Meena, Uppal M S, Yamini, Batra A P S, Sambyal Vasudha

Affiliations

  1. Department of Human Genetics, Guru Nanak Dev University, Amritsar, Punjab-143 005, India.

PMID: 20407644 PMCID: PMC2846563 DOI: 10.4103/0971-6866.50864

Abstract

Genomic instability in the tumor tissue has been correlated with tumor progression. In the present study, chromosomal aberrations (CAs) in peripheral blood lymphocytes (PBLs) of breast tumor patients were studied to assess whether chromosomal instability (CIN) in PBLs correlates with aggressiveness of breast tumor (i.e., disease stage) and has any prognostic utility. Cultured blood lymphocyte metaphases were scored for aberrations in 31 breast cancer patients and 20 healthy age and sex-matched controls. A variety of CAs, including aneuploidy, polyploidy, terminal deletions, acentric fragments, double minutes, chromatid separations, ring chromosome, marker chromosome, chromatid gaps, and breaks were seen in PBLs of the patients. The CAs in patients were higher than in controls. A comparison of the frequency of metaphases with aberrations by grouping the patients according to the stage of advancement of disease did not reveal any consistent pattern of variation in lymphocytic CIN. Neither was any specific chromosomal abnormality found to be associated with the stage of cancer. This might be indicative of the fact that cancer patients have constitutional CIN, which predisposes them to the disease, and this inherent difference in the level of genomic instability might play a role in disease progression and response to treatment.

Keywords: Breast cancer; chromosomal aberrations; genomic instability; lymphocytes

References

  1. Oncol Rep. 2001 Sep-Oct;8(5):1001-5 - PubMed
  2. Anticancer Res. 1991 May-Jun;11(3):1055-60 - PubMed
  3. Trends Cell Biol. 1999 Dec;9(12):M57-60 - PubMed
  4. Epidemiology. 2004 Jul;15(4):442-50 - PubMed
  5. Int J Radiat Oncol Biol Phys. 2001 Feb 1;49(2):533-7 - PubMed
  6. BMJ. 2000 Sep 9;321(7261):624-8 - PubMed
  7. Environ Health Perspect. 2005 May;113(5):517-20 - PubMed
  8. Cytogenet Genome Res. 2004;104(1-4):376-82 - PubMed
  9. Ann Genet. 1994;37(4):192-5 - PubMed
  10. J Cell Biol. 2008 Feb 25;180(4):665-72 - PubMed
  11. Proc Natl Acad Sci U S A. 2001 May 8;98(10):5770-5 - PubMed
  12. Hum Genet. 1991 Nov;88(1):39-41 - PubMed
  13. Cancer Epidemiol Biomarkers Prev. 1998 Sep;7(9):783-9 - PubMed
  14. Nat Rev Cancer. 2001 Nov;1(2):109-17 - PubMed
  15. Cancer. 1999 Jun 1;85(11):2400-9 - PubMed
  16. Ann Surg. 2001 Dec;234(6):795-802; discussion 802-3 - PubMed
  17. Mutat Res. 2008 Mar 12;651(1-2):93-104 - PubMed
  18. Environ Health Perspect. 1993 Oct;101 Suppl 3:169-75 - PubMed
  19. Am J Epidemiol. 2007 Jan 1;165(1):36-43 - PubMed
  20. Hum Pathol. 2000 Feb;31(2):201-7 - PubMed
  21. Nat Rev Cancer. 2004 Apr;4(4):266-76 - PubMed
  22. Exp Cell Res. 1960 Sep;20:613-6 - PubMed
  23. Breast Cancer Res Treat. 1998 Mar;48(2):187-90 - PubMed
  24. Epidemiol Rev. 1993;15(1):36-47 - PubMed
  25. Cancer Res. 2004 Mar 15;64(6):2258-63 - PubMed
  26. Int J Oncol. 2000 Aug;17(2):399-404 - PubMed

Publication Types